Schedule 13G ownership disclosure
Arsanis, Inc.
Security class unavailable · CUSIP: 042873109
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 722,179
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-18-000200
- Form type
- SC 13G
- Filer
- X4 Pharmaceuticals, Inc
- CIK
- CIK 1501697
- Filed
- Feb 13, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership